Vitestro has announced that its automated blood drawing device has received CE marking. This acknowledges that the device meets the requirements of the European Medical Device Regulation (MDR) and is now approved for commercial use across the European Union. Vitestro says it is the first company ever to achieve CE marking for an autonomous blood drawing device.

Through a combination of advanced imaging technology and robotics, Vitestro says the device enables hospitals and labs to provide accurate autonomous blood draws, reducing the need for manual handling and improving patient and clinician satisfaction. Vitestro has managed to automate the missing step in total lab automation. This is critical as clinical laboratories are experiencing a severe staffing shortage.

Co-founder and CEO, Toon Overbeeke said: “While this CE marking represents a major step forward for Vitestro, it also marks a transformational moment for healthcare at large. This innovation introduces a completely novel type of medical device, one that allows European hospitals to use autonomous technology to perform invasive medical procedures independently. We believe this technology is foundational, setting a new global standard that will benefit patients and help hospitals prepare for a challenging future.”